Assay Development, Biophysical Assays and Fragment Screening

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Assay Development

Biophysical Assays

Fragment Screening

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. In terms of compound libraries, we have a high-throughput screening library of about 200,000 ligands. We can screen with many different formats and modalities.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

Biophysics

Sygnature Discovery

JUNE 17, 2024

Comprehensive Assay Development for Diverse Applications Our team here at Sygnature Discovery, comprised of expert biophysicists, is highly experienced in a variety of target classes and drug modalities. Sygnature Discovery’s Biophysical Assay Development Capabilities: 1.

Biophysical Assays

Biophysical Assays Screening Hits Assay Development Fragment Screening

Drug Discovery Digest

Target-directed cancer: protein-ligand interactions

Biophysics

Stay Connected